EVP Chief Commercial Officer of Dexcom Inc (30-Year Financial, Insider Trades) Richard Doubleday (insider trades) sold 1,531 shares of DXCM on 07/23/2020 at an average price of $427.29 a share. The total sale was $654,181.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. DexCom Inc has a market cap of $39.93 billion; its shares were traded at around $423.43 with a P/E ratio of 266.30 and P/S ratio of 24.51. GuruFocus has detected 3 severe warning signs with DexCom Inc. .
CEO Recent Trades:
- President, CEO and Chairman Kevin R Sayer sold 6,000 shares of DXCM stock on 07/06/2020 at the average price of $420.94. The price of the stock has increased by 0.59% since.
Directors and Officers Recent Trades:
- EVP Strategy and Corporate Dev Steven Robert Pacelli sold 1,531 shares of DXCM stock on 07/23/2020 at the average price of $427.31. The price of the stock has decreased by 0.91% since.
- EVP Chief Commercial Officer Richard Doubleday sold 1,531 shares of DXCM stock on 07/23/2020 at the average price of $427.29. The price of the stock has decreased by 0.9% since.
- Director Steven R Altman sold 2,000 shares of DXCM stock on 07/10/2020 at the average price of $437.5. The price of the stock has decreased by 3.22% since.
- SVP Information Technology Shelly Ramasamy Selvaraj sold 400 shares of DXCM stock on 07/10/2020 at the average price of $439.33. The price of the stock has decreased by 3.62% since.
- EVP, Chief Legal Officer Patrick Michael Murphy sold 500 shares of DXCM stock on 07/09/2020 at the average price of $435.8. The price of the stock has decreased by 2.84% since.
For the complete insider trading history of DXCM, click here
.
